Aims & Scope

The International Journal of Keratoconus and Ectatic Corneal Diseases is a peer-reviewed journal covering keratoconus and other ectatic corneal diseases, including pellucid marginal degeneration, Terrien's marginal degeneration, keratoglobus and iatrogenic keratoconus, such as post-LASIKectasia. Studies dealing with epidemiology, genetics, pathology and corneal biomechanics are welcomed. The journal covers new diagnostic tools that aid in the diagnosis of keratoconus and ectatic corneal diseases including their role in refractive surgery. The journal deals with new treatment modalities, such as collagen corneal cross-linking, intrastromal corneal rings, anterior lamellar keratoplasty, deep anterior lamellar keratoplasty and the applications of femtosecond lasers in penetrating kertoplasty and corneal surgery. In addition, the journal covers the use of excimer laser in corneal surgery. Special interest is drawn to contact lenses and their use in keratoconus and ectatic corneal diseases.

The above-mentioned topics have a crucial role in the clinical practice and day-to-day management. The journal aims to publish articles arising out of original research, specialized topics, review articles, editorials and descriptions of new diagnostic and therapeutic techniques and technologies. In addition, the journal includes pictorial reviews, letters to the editor, book reviews and notices of meetings and courses. In this way, the journal hopes to provide a forum for the stimulation of new developments, clinical practices and research in its field.

Ownership and Management

International Journal of Keratoconus and Ectatic Corneal Diseases is owned and managed under Jaypee Brothers Medical Publishers. 

About the Publisher

Jaypee Brothers Medical Publishers (P) Ltd is committed to supporting health, medical and dental research communities across continents. Jaypee Journals, a division of Jaypee Brothers Medical Publishers is one of the largest medical publishers in the world and provides high-quality open-access journals that are trustworthy, authoritative, and accessible to researchers. We provide high-quality support at all stages of the publishing cycle so that we can help researchers publish their work. We are the partners of success for researchers through global standard publishing as well as open access. We are the partners of success for researchers through global standard publishing as well as open access.

Publication Frequency

International Journal of Keratoconus and Ectatic Corneal Diseases publishes bi-annually (June and December) focussing on keratoconus and other ectatic corneal diseases.

Digital Preservation / Archiving:

International Journal of Keratoconus and Ectatic Corneal Diseases  provides for long-term digital preservation through PORTICO.

Portico is a leading digital preservation service worldwide. The content is preserved as an archival version and is not publically accessible via Portico, but is provided when required under specific conditions, such as discontinuation of the collection or catastrophic failure of the website.

Copyright and Licensing

Under Creative Commons the Authors retain ownership/ copyright of their content. The authors assign exclusive commercial re-use rights of the article to the Publisher. 

All open access articles published are distributed under the terms of the CC BY-NC 4.0 license (Creative Commons Attribution-Non-Commercial 4.0 International Public License as currently displayed at http://creativecommons.org/licenses/by-nc/4.0/legalcode) which permits unrestricted use, distribution, and reproduction in any medium, for non-commercial purposes, provided the original work is properly cited. 

Authors have to mandatorily submit the Open Access License Agreement Form when submitting the manuscript. 

Articles published under this arrangement are made freely available online upon publication without subscription barriers to access. Users of such published articles are entitled to use, reproduce, disseminate, or display these articles for personal, research and educational use provided that: 

• The original authorship is properly and fully attributed. 

• The journal and publisher are attributed as the original place of publication with correct citation details given. 

• If an original work is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work, this is clearly indicated. 

• No articles are reproduced for commercial use without the prior consent of the Publisher. All the licensing requests and permissions for commercial use of the article will be managed by the Publisher. For re-use of the content for other purposes that are not covered by the CC BY-NC license, please contact  journals.permissions@jaypeebrothers.com 

• Authors are also entitled to deposit the final electronic version of the article into an institutional or centrally organized subject repository upon publication. They should include a link to the published version of the article on the journal's web site, and the journal and publisher should be attributed as the original place of publication, with correct citations given. 

Open Access Policy

A comprehensive outlook on open access policy that we follow:

Open access refers to the practice of making peer-reviewed scholarly research and literature freely available online to anyone interested in reading it at no cost and with limited restrictions with regards to reuse.  Open access publications are freely and permanently available online to anyone with an internet access. The journal allows unrestricted use, distribution and reproduction in any medium (which is non-commercial), provided the article is properly attributed. All the articles are published, without any technical, financial, gender limitations, in an agreed format on the journal website and deposited in archive and indexing databases as applicable to the journal. All articles are assigned a Digital Object Identifier (DOI), thereby making it fully citable and searchable by title, author name(s) and the full text.  

Why open access publishing?

Restricted access to scientific research and advancements through subscription pay wall hinders communication within the scientific community. Moreover, restricted access can also hinder the education and dissemination of scientific knowledge to the aspiring younger generations who are keen to pursue a career in science. Increased productivity and development of science can only be achieved by diffusing knowledge and providing the facilities for creating permanent repositories such as Open Access. 

The use of a Creative Commons 4.0 License (CC-BY-NC 4.0) enables user/reader/peer to use the content with clear permission in a way that it can be reused and redistributed as long as the article source is appropriately given credit for non-commercial purpose. 

Self-Archiving Policy for Authors

Authors are encouraged to deposit the final published PDF in their institutional repository or any suitable subject repository (according to the end-user license of the article, i.e., strictly for non-commercial re-use) immediately upon publication. The deposited version should contain the URL and link to the online published version on the publisher’s website to clearly identify it as the definitive version of record.

Abstract and Citation information

Authors can share the Abstract and “How to cite” information (e.g., Title, Author name, Publication dates) of their article anywhere at any time including social media such as Facebook, blogs and Twitter, with proper attribution to the original source (the Publisher website) or include the DOI number in the social media post that links it to the published article on the Journal website.

Submitted Version

Submitted version (SV) or the preprint version is recognized as the author version of an article before submission to a journal for peer review. The author accepts full responsibility for the article, and the content and layout are set out by the author. 

Authors can post their preprint version on preprint servers of the authors’ choice, authors’ or institutional websites, preprint servers or preprint commenting platforms, intended for non-commercial use. When submitting the manuscript to the journal, authors must disclose all pertinent information regarding preprint publication, such as the DOI and licencing terms. The author must make sure that the preprint record is updated with a publication reference after it is published, including the DOI and a URL link to the journal website where the paper has been published. 

Accepted Manuscript

The accepted manuscript (AM) is the peer reviewed version (not the final published version) as accepted for publication by the journal that includes modifications based on reviewers’ suggestions. This version excludes copy editing and type setting changes.  

The journal does not recommend the authors to upload AM to their personal website/ institutional or other non-commercial subject-based repositories. 

Published Version

Published Version (PV) is defined as the final version of the article that has been made available by the Publisher on the respective journal website by formally and exclusively putting the article either in ‘online first’ or releasing it as a part of the complete issue of that journal. This is the final, definitive, citable version of your paper, which has been copyedited, typeset, has metadata applied, and has been allocated a DOI. 

Authors may share the PV with private groups within their institution or through private groups on non-commercial repositories that are signatories to the STM Voluntary principles for article sharing on Scholarly Collaboration Networks (SCN). The PV may not be uploaded or shared on commercial websites or repositories unless the website or repository has signed an agreement with the publisher permitting such uploading or sharing. 

Publication Ethics and Malpractice Statement

This Publication Ethics and Malpractice Statement is based on the Code of Conduct and Best Practice Guidelines for Journal Editors as per Committee on Publication Ethics, ICMJE & WAME. Please visit Policy page for more details. 

Advertisement Policy

1. Journals carry advertisements both digitally and in print. All these commercially sponsored advertisements are independent of editorial decisions. 

2. Journal and the Publisher do not endorse any product or service marked as an advertisement or promoted by a sponsor in any of our publications. Editorial content is not compromised by commercial or financial interests, or by any specific arrangements with advertising clients or sponsors. 

3. Journal and the Publisher reserves the right to decline any type of advertising that is damaging to the brand or is inappropriate to the content or deceptive or misleading. The content in the advertisements should be verifiable.  

4. Advertisements will not be accepted if they appear to be indecent or offensive in either text or artwork, or if they are discriminatory in terms of personal, racial, ethnic, sexual orientation, or religious nature. 

5. Journal and the Publisher will not accept advertising for products or services known to be harmful to health (e.g., tobacco and alcohol products). 

6. Even if the advertisement has been implemented online, it will be withdrawn from the journal site at any time if the Journal and the Publisher feel it is inappropriate. 

7. The product advertorial will not allow any treatment-specific or drug-specific campaign to be targeted to a specific article(s) on any page where content related to the product(s) is being advertised. 

8. Advertisers should make available to the Publisher, the marketing authorization and summary of product characteristics when submitting their advertisement. In the case of drug advertisements, the full generic name of each active ingredient should be clearly stated. 

9. Editorial decisions will not be influenced by current or potential sponsors and advertisers and will not be influenced by marketing decisions. 

10. Information about complaints concerning advertisements will be included in the Advertisements page in Print copies only.